Search results
Results from the WOW.Com Content Network
Year of discovery Name of the drug Active ingredients 1st millennium BC: Hyoscyamus niger: Tropane alkaloids (e.g. hyoscyamine and scopolamine). [16] 600 B.C. Glycerol, produced: Glycerol [citation needed] 300 B.C. Opium: Phenanthrenes (e.g. morphine, codeine, and thebaine). [17] Morphine binds to and activates Mu opioid receptors and is analgesic.
Drug Design, Development and Therapy; Drug Development and Industrial Pharmacy; Drug Discovery Today; Drug, Healthcare and Patient Safety; Drug Safety; Drug Metabolism Reviews; Drug Testing and Analysis; European Heart Journal - Cardiovascular Pharmacotherapy; European Journal of Pharmaceutical Sciences; European Journal of Pharmaceutics and ...
Despite the rise of combinatorial chemistry as an integral part of lead discovery process, natural products still play a major role as starting material for drug discovery. [56] A 2007 report [ 57 ] found that of the 974 small molecule new chemical entities developed between 1981 and 2006, 63% were natural derived or semisynthetic derivatives ...
This is a list of journals published by Nature Research. These include the flagship Nature journal, the Nature Reviews series (which absorbed the former Nature Clinical Practice series in 2009), the npj series, Scientific Reports and many others.
This is the timeline of modern [clarification needed] antimicrobial [clarification needed] (anti-infective) therapy. The years show when a given drug was released onto the pharmaceutical market. This is not a timeline of the development of the antibiotics themselves.
AI in drug development successes The world's first COVID-19 drug designed by generative AI is approved for human use, with clinical trials expected to begin in China. The new drug, ISM3312, is developed by Insilico Medicine. [389] A new AI algorithm developed by Baidu is shown to boost the antibody response of COVID-19 mRNA vaccines by 128 ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
It was established in 2002 [1] and covers drug discovery and development. The editor-in-chief is Peter Kirkpatrick. [ 2 ] According to the Journal Citation Reports , the journal has a 2021 impact factor of 112.288, ranking it 1st out of 158 journals in the category "Biotechnology & Applied Microbiology" [ 3 ] and 1st out of 279 journals in the ...